首页> 美国卫生研究院文献>other >THE AP-2 CLATHRIN ADAPTOR MEDIATES ENDOCYTOSIS OF AN INHIBITORY KILLER CELL Ig-LIKE RECEPTOR (KIR) IN HUMAN NK CELLS
【2h】

THE AP-2 CLATHRIN ADAPTOR MEDIATES ENDOCYTOSIS OF AN INHIBITORY KILLER CELL Ig-LIKE RECEPTOR (KIR) IN HUMAN NK CELLS

机译:AP-2网格蛋白适配器介导人类NK细胞抑制性杀伤细胞Ig样受体(KIR)的内吞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stable surface expression of human inhibitory killer cell immunoglobulin-like receptors (KIR) is critical for controlling NK cell function and maintaining NK cell tolerance toward normal MHC-I+ cells. Our recent experiments, however, have found that antibody-bound KIR3DL1 (3DL1) readily leaves the cell surface and undergoes endocytosis to early/recycling endosomes and subsequently to late endosomes. We found that 3DL1 internalization is at least partially mediated by an interaction between the μ2 subunit of the AP-2 clathrin adaptor complex and ITIM tyrosine residues in the cytoplasmic domain of 3DL1. Disruption of the 3DL1/μ2 interaction, either by mutation of the ITIM tyrosines in 3DL1 or mutation of μ2, significantly diminished endocytosis and increased surface expression of 3DL1 in human primary NK cells and cell lines. Furthermore, we found that the 3DL1/AP-2 interaction is diminished upon antibody engagement with the receptor, as compared to untreated cells. Thus, we have identified AP-2-mediated endocytosis as a mechanism regulating the surface levels of inhibitory KIR though their ITIM domains. Based upon our results, we propose a model in which non-engaged KIR are internalized by this mechanism, whereas engagement with MHC-I ligand would diminish AP-2 binding, thereby prolonging stable receptor surface expression and promoting inhibitory function. Furthermore, this ITIM-mediated mechanism may similarly regulate the surface expression of other inhibitory immune receptors.
机译:人类抑制性杀伤细胞免疫球蛋白样受体(KIR)的稳定表面表达对于控制NK细胞功能和维持NK细胞对正常MHC-I + 细胞的耐受性至关重要。但是,我们最近的实验发现,结合抗体的KIR3DL1(3DL1)容易离开细胞表面,并向早期/回收内体和后期内体进行内吞。我们发现3DL1内在化至少部分是由AP-2网格蛋白衔接子复合体的μ2亚基与3DL1胞质域中的ITIM酪氨酸残基之间的相互作用介导的。通过3TIM1中ITIM酪氨酸突变或μ2突变破坏3DL1 /μ2相互作用,可显着减少人原代NK细胞和细胞系中的内吞作用和3DL1表面表达的增加。此外,我们发现与未处理的细胞相比,抗体与受体结合后3DL1 / AP-2相互作用减少。因此,我们已经确定AP-2介导的内吞作用是通过ITIM域调节抑制性KIR表面水平的一种机制。根据我们的结果,我们提出了一个模型,其中未参与的KIR通过这种机制内在化,而与MHC-1配体的结合会减少AP-2的结合,从而延长稳定的受体表面表达并促进抑制功能。此外,这种ITIM介导的机制可能类似地调节其他抑制性免疫受体的表面表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号